Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 143


Contrast ultrasound for the quantification of deep vein thrombosis in living mice: effects of enoxaparin and P2Y12 receptor inhibition.

Guenther F, Herr N, Mauler M, Witsch T, Roming F, Hein L, Boeynaems JM, Robaye B, Idzko M, Bode C, Von Zur Muhlen C, Duerschmied D.

J Thromb Haemost. 2013 Jun;11(6):1154-62. doi: 10.1111/jth.12206.


Signaling via P2Y12 may be critical for early stabilization of platelet aggregates.

Speich HE, Bhal V, Houser KH, Caughran AT, Lands LT, Houng AK, Bäckstrom J, Enerbäck M, Reed GL, Jennings LK.

J Cardiovasc Pharmacol. 2014 Jun;63(6):520-7. doi: 10.1097/FJC.0000000000000076.


In vivo monitoring of venous thrombosis in mice.

Aghourian MN, Lemarié CA, Blostein MD.

J Thromb Haemost. 2012 Mar;10(3):447-52. doi: 10.1111/j.1538-7836.2011.04615.x.


A clopidogrel-insensitive inducible pool of P2Y12 receptors contributes to thrombus formation: inhibition by elinogrel, a direct-acting, reversible P2Y12 antagonist.

Haberstock-Debic H, Andre P, Mills S, Phillips DR, Conley PB.

J Pharmacol Exp Ther. 2011 Oct;339(1):54-61. doi: 10.1124/jpet.111.184143. Epub 2011 Jul 5.


Lack of clinically significant pharmacological interactions between ticagrelor and enoxaparin or unfractionated heparin in healthy subjects.

Teng R, Butler K.

J Clin Pharm Ther. 2012 Dec;37(6):704-11. doi: 10.1111/j.1365-2710.2012.01367.x. Epub 2012 Jul 2.


Thrombogenesis with continuous blood flow in the inferior vena cava. A novel mouse model.

Diaz JA, Hawley AE, Alvarado CM, Berguer AM, Baker NK, Wrobleski SK, Wakefield TW, Lucchesi BR, Myers DD Jr.

Thromb Haemost. 2010 Aug;104(2):366-75. doi: 10.1160/TH09-09-0672. Epub 2010 Jun 29.


Enhanced platelet reactivity and thrombosis in Apoe-/- mice exposed to cigarette smoke is attenuated by P2Y12 antagonism.

Dong A, Caicedo J, Han SG, Mueller P, Saha S, Smyth SS, Gairola CG.

Thromb Res. 2010 Oct;126(4):e312-7. doi: 10.1016/j.thromres.2010.03.010. Epub 2010 May 10.


Molecular imaging of fibrin deposition in deep vein thrombosis using fibrin-targeted near-infrared fluorescence.

Hara T, Bhayana B, Thompson B, Kessinger CW, Khatri A, McCarthy JR, Weissleder R, Lin CP, Tearney GJ, Jaffer FA.

JACC Cardiovasc Imaging. 2012 Jun;5(6):607-15. doi: 10.1016/j.jcmg.2012.01.017.


The antithrombotic effects of CI-1031 (ZK-807834) and enoxaparin in a canine electrolytic injury model of arterial and venous thrombosis.

McClanahan TB, Hicks GW, Morrison AL, Peng YW, Janiczek-Dolphin N, Mertz TE, Sullivan ME, Morser J, Juneau PL, Leadley R.

Eur J Pharmacol. 2001 Dec 7;432(2-3):187-94.


Diagnosis of benign and malignant portal vein thrombosis in cirrhotic patients with hepatocellular carcinoma: color Doppler US, contrast-enhanced US, and fine-needle biopsy.

Tarantino L, Francica G, Sordelli I, Esposito F, Giorgio A, Sorrentino P, de Stefano G, Di Sarno A, Ferraioli G, Sperlongano P.

Abdom Imaging. 2006 Sep-Oct;31(5):537-44.


Vein wall re-endothelialization after deep vein thrombosis is improved with low-molecular-weight heparin.

Moaveni DK, Lynch EM, Luke C, Sood V, Upchurch GR, Wakefield TW, Henke PK.

J Vasc Surg. 2008 Mar;47(3):616-24. doi: 10.1016/j.jvs.2007.11.040.


Competitive mode and site of interaction of ticagrelor at the human platelet P2Y12 -receptor.

Hoffmann K, Lutz DA, Straßburger J, Baqi Y, Müller CE, von Kügelgen I.

J Thromb Haemost. 2014 Nov;12(11):1898-905. doi: 10.1111/jth.12719. Epub 2014 Sep 29.


Stabilizing role of platelet P2Y(12) receptors in shear-dependent thrombus formation on ruptured plaques.

Nergiz-Unal R, Cosemans JM, Feijge MA, van der Meijden PE, Storey RF, van Giezen JJ, oude Egbrink MG, Heemskerk JW, Kuijpers MJ.

PLoS One. 2010 Apr 12;5(4):e10130. doi: 10.1371/journal.pone.0010130.


Ticagrelor effectively and reversibly blocks murine platelet P2Y12-mediated thrombosis and demonstrates a requirement for sustained P2Y12 inhibition to prevent subsequent neointima.

Patil SB, Jackman LE, Francis SE, Judge HM, Nylander S, Storey RF.

Arterioscler Thromb Vasc Biol. 2010 Dec;30(12):2385-91. doi: 10.1161/ATVBAHA.110.210732. Epub 2010 Nov 11.


Increased platelet activation and thrombosis in transgenic mice expressing constitutively active P2Y12.

Zhang Y, Ye J, Hu L, Zhang S, Zhang SH, Li Y, Kunapuli SP, Ding Z.

J Thromb Haemost. 2012 Oct;10(10):2149-57. doi: 10.1111/j.1538-7836.2012.04894.x.


Impact of antithrombin deficiency on efficacy of edoxaban and antithrombin-dependent anticoagulants, fondaparinux, enoxaparin, and heparin.

Fukuda T, Kamisato C, Honda Y, Matsushita T, Kojima T, Furugohri T, Morishima Y, Shibano T.

Thromb Res. 2013 Jun;131(6):540-6. doi: 10.1016/j.thromres.2013.04.016. Epub 2013 May 11.


Role of newly formed platelets in thrombus formation in rat after clopidogrel treatment: comparison to the reversible binding P2Y₁₂ antagonist ticagrelor.

Kuijpers MJ, Megens RT, Nikookhesal E, Feijge MA, De Mey JG, oude Egbrink MG, van Giezen JJ, Heemskerk JW.

Thromb Haemost. 2011 Dec;106(6):1179-88. doi: 10.1160/TH11-04-0252. Epub 2011 Nov 10.


A murine model of deep vein thrombosis: characterization and validation in transgenic mice.

Cooley BC, Szema L, Chen CY, Schwab JP, Schmeling G.

Thromb Haemost. 2005 Sep;94(3):498-503.


Vein wall remodeling after deep vein thrombosis: differential effects of low molecular weight heparin and doxycycline.

Sood V, Luke C, Miller E, Mitsuya M, Upchurch GR Jr, Wakefield TW, Myers DD, Henke PK.

Ann Vasc Surg. 2010 Feb;24(2):233-41. doi: 10.1016/j.avsg.2009.11.002.


High-dose aspirin in dogs increases vascular resistance with limited additional anti-platelet effect when combined with potent P2Y12 inhibition.

Björkman JA, Zachrisson H, Forsberg GB, von Bahr H, Hansson GI, Warner TD, Nylander S.

Thromb Res. 2013 Apr;131(4):313-9. doi: 10.1016/j.thromres.2013.01.029. Epub 2013 Feb 15.


Supplemental Content

Support Center